Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
Insider trades, last 90 days
0 buys · 5 sells
- Sold $34K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
215
- +7 vs. Q1 2026
- Total value $389.6M
Superinvestors holding EDIT
0
- None of the superinvestors held EDIT at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by EDIT insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 20264:27 PM ET | Sep 3, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | SSaleCommon Stock | −709 | $3.0372 | −$2.15K | 61.66K | −1.1% | SEC10b5-1 |
| Sep 4, 20264:25 PM ET | Sep 3, 2026 | Parison AmySVP, Chief Financial Officer | SSaleCommon Stock | −453 | $3.0372 | −$1.38K | 13.84K | −3.2% | SEC10b5-1 |
| Sep 4, 20264:22 PM ET | Sep 3, 2026 | O'Neill Gilmore NeilCEO | SSaleCommon Stock | −5.12K | $3.0372 | −$15.56K | 243.19K | −2.1% | SEC10b5-1 |
| Aug 5, 20264:07 PM ET | Aug 3, 2026 | Parison AmySVP, Chief Financial Officer | SSaleCommon Stock | −678 | $2.58 | −$1.75K | 14.29K | −4.5% | SEC10b5-1 |
| Jul 29, 20264:51 PM ET | Jul 28, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | SSaleCommon Stock | −4.93K | $2.67 | −$13.16K | 62.37K | −7.3% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in EDIT at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 11,111,111 | $36M | 0.87% | +11,111,111 | New |
| BlackRock, Inc. | 10,589,990 | $34.31M | 0.00% | +1,326,678+14.3% | Added |
| RA CAPITAL MANAGEMENT, L.P. | 8,889,000 | $28.8M | 0.25% | +8,889,000 | New |
| COMMODORE CAPITAL LP | 8,889,000 | $28.8M | 1.72% | +8,889,000 | New |
| ADAR1 Capital Management, LLC | 8,889,000 | $28.8M | 1.35% | +8,889,000 | New |